Pharmacotherapy of Alzheimer's disease:
โ
Bengt Winblad; Henry Brodaty; Serge Gauthier; John C Morris; Jean-Marc Orgogozo;
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 138 KB
## Abstract The traditional aim of Alzheimer's disease treatment in clinical trials has been to improve cognitive abilities. It has become increasingly clear, however, that other aspects are important in assessing treatment responses. A group of 10 physicians recently gathered to review the current